ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $14,187,000 | +46.7% | 306,225 | -22.8% | 0.02% | +41.7% |
| Q1 2019 | $9,671,000 | -12.5% | 396,675 | -48.9% | 0.01% | -20.0% |
| Q4 2018 | $11,051,000 | -7.4% | 775,525 | -1.3% | 0.02% | +7.1% |
| Q3 2018 | $11,940,000 | -3.8% | 785,525 | +6.1% | 0.01% | 0.0% |
| Q2 2018 | $12,418,000 | -6.1% | 740,025 | -8.7% | 0.01% | -6.7% |
| Q1 2018 | $13,231,000 | +980.1% | 810,725 | +746.9% | 0.02% | +1400.0% |
| Q4 2017 | $1,225,000 | +58.1% | 95,725 | +51.9% | 0.00% | 0.0% |
| Q3 2017 | $775,000 | +592.0% | 63,000 | +156.0% | 0.00% | – |
| Q3 2015 | $112,000 | -38.5% | 24,610 | -2.7% | 0.00% | – |
| Q2 2015 | $182,000 | -18.4% | 25,290 | -16.3% | 0.00% | – |
| Q1 2015 | $223,000 | +60.4% | 30,210 | +2.8% | 0.00% | – |
| Q4 2014 | $139,000 | +16.8% | 29,390 | -12.0% | 0.00% | – |
| Q3 2014 | $119,000 | +45.1% | 33,390 | +86.4% | 0.00% | – |
| Q2 2014 | $82,000 | -19.6% | 17,910 | -17.5% | 0.00% | – |
| Q1 2014 | $102,000 | +5.2% | 21,720 | +12.7% | 0.00% | – |
| Q4 2013 | $97,000 | -15.7% | 19,270 | +4.3% | 0.00% | – |
| Q3 2013 | $115,000 | – | 18,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |